查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
血酮仪市场-增长、趋势、COVID-19 影响和预测 (2023-2028)
市场调查报告书
商品编码
1190112

血酮仪市场-增长、趋势、COVID-19 影响和预测 (2023-2028)

Blood Ketone Meter Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计血酮仪市场在预测期内（2022 年至 2027 年）的复合年增长率为 6.7%。

预计 COVID-19 大流行将对市场产生重大影响。 糖尿病发病率的增加和糖尿病酮症酸中毒病例的增加预计将推动市场增长。 根据美国糖尿病协会的说法，糖尿病患者感染 COVID-19 后更容易出现并发症。 根据国际糖尿病联合会 (IDF) 2019 年的一份报告，糖尿病影响了全球约 4.63 亿 20 至 79 岁的成年人，到 2045 年将达到 7 亿。据预测，

由于设备的技术进步，预计该市场将显着增长。 比如Foracare的血糖血酮仪“FORA 6 Gtel”就具备了3G/4G连接功能。 FORA 6 测试条采用 5 电极设计和金条，可确保高精度和准确度。 可测血糖、血细胞比容、血红蛋白、B酮、总胆固醇、尿酸6项。 此外，无需与智能手机配对，即可轻鬆将数据传输至远程健康管理系统。 由于这些因素，预计该市场将在预测期内扩大。

主要市场趋势

血酮仪领域有望占据主要市场份额

血酮仪部门认为，这些设备可能有助于及早发现酮体产生，警告即将发生的酮症酸中毒，并最终减少糖尿病酮症酸中毒的并发症。因此，它已经占据了很大的市场份额。 糖尿病酮症酸中毒和糖尿病患病率上升是推动市场增长的主要因素之一。 此外，世界上老年人和肥胖人口的增加预计将推动市场增长。 根据世界卫生组织 (WHO) 的数据，到 2050 年，世界上 60 岁及以上的人口将达到 20 亿。 根据国际糖尿病联合会于 2021 年 9 月更新的糖尿病事实与数据，全球约有 5.37 亿成年人患有糖尿病。 预计到 2030 年将增加到 6.43 亿，到 2045 年将增加到 7.83 亿。 这可能会增加对血酮体市场的需求，因为这些设备可以测量血液中的酮体水平。

由于伙伴关係和协作的增加，该领域有望实现显着增长。 例如，2020 年 2 月，全球糖尿病非营利组织 Beyond Type 宣布与全国学校护士协会建立新的合作伙伴关係，以提高人们对 1 型糖尿病 (T1D) 警告信号的认识。 这一新的合作伙伴关係将向全美数千名学校护士分发教育材料。 提高认识计划将使有糖尿病风险的人更容易参与以证据为基础的生活方式改变计划，以降低他们患糖尿病的风险，这可能会在预测期内推动市场。 市场进入者获得了 CE（Conformite Europeenne）和 FDA（食品和药物管理局）先进血酮仪的批准，获得了更大的市场份额，尖端技术产品帮助人们轻鬆追踪他们的血酮水平。 例如，Abbott 的 FreeStyle Optium Neo 是一款超薄轻便的血糖仪，可放入您的口袋，并在一米内提供准确的血糖和酮读数。 因此，预计在预测期内，全球范围内产品批准的增加将提振市场。

预计在预测期内北美将占据重要的市场份额

北美主导着血酮仪市场。 由于该地区主要参与者的各种合併、合作和收购，预计在预测期内将保持这种状态。 2019 年 3 月，血糖和酮体测试製造商 Keto Mojo 与个人健康数据分析软件公司 Heads Up Health 合作，开发了可与酮测量仪同步的 Keto-Mojo App。 这种集成将使 Keto Mojo 用户能够跟踪他们的健康状况。 2020 年 3 月，EKF Diagnostics 宣布在美国市场推出其 FDA CLIA 豁免 B 酮和葡萄糖 POC 分析仪 STAT-Site WB Analyzer。 STAT-Site WB 在糖尿病管理中可兼作专业全血 B 酮和血糖仪。

医疗设施中质量更高的基础设施和整个地区血酮监测器的更多采用，尤其是在 COVID-19 流行期间，预计将有助于北美市场的增长。 据推测，政府促进葡萄糖和酮体监测的举措将显着推动市场。 根据美国疾病控制与预防中心于 2021 年 8 月更新的国家糖尿病预防计划，美国政府正在努力製定国家糖尿病预防计划等意识计划，以解决前驱糖尿病和 2 型糖尿病日益增加的负担。 该倡议在公共和私人机构之间建立了伙伴关係，以提供具有成本效益的干预措施和循证治疗，以帮助在美国预防 2 型糖尿病。

预计糖尿病患者的增加将增加对测量酮体水平的血酮仪的需求。 例如，根据疾病预防控制中心的数据，美国约有 10.5% 的人口患有糖尿病，2020 年美国约有 2690 万人被诊断出患有糖尿病。 据美国糖尿病协会称，2018 年将有约 21 万名 20 岁以下的美国人被诊断出患有糖尿病。 年轻人中糖尿病患者的这种增加预计会产生对血酮仪的需求。

竞争格局

血酮仪市场相当分散，有一些主要和较小的参与者。 市场参与者专注于研发，为市场开发技术先进的产品。 市场上的主要参与者包括 Abbott Laboratories、Nova Biomedical、Nipro Corporation、TaiDoc Technology Corporation、ForaCare Inc.、A. Menarini Diagnostics Srl。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 糖尿病患病率上升
    • 增加产品发布和批准
  • 市场製约因素
    • 产品召回率增加
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分

  • 产品类型
    • 血酮计
    • 血糖/酮计
    • 消耗品
  • 用法
    • 人体
    • 对于动物
  • 最终用户
    • 医院和诊所
    • 诊断中心
    • 其他最终用户
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 世界其他地区

第六章竞争格局

  • 公司简介
    • Abbott Laboratories
    • Nova Biomedical
    • Nipro Corporation
    • TaiDoc Technology Corporation
    • ForaCare Inc.
    • A. Menarini Diagnostics Srl
    • ACON Laboratories Inc.
    • APEX Biotechnology Corporation
    • EKF Diagnostics
    • GlucoRx Ltd
    • MED TRUST
    • KETO-MOJO
    • PortaScience Inc.

第7章 市场机会今后动向

简介目录
Product Code: 72500

The blood ketone meter market is projected to register a CAGR of 6.7% during the forecast period (2022-2027).

The COVID-19 pandemic is expected to have a significant impact on the market. An increase in the incidence of diabetes and rising cases of diabetic ketoacidosis are expected to drive market growth. According to the American Diabetes Association, people with diabetes are more likely to have worse complications if affected by COVID-19. According to the International Diabetes Federation's (IDF) report published in 2019, globally, around 463 million adults aged 20 to 79 years were suffering from diabetes, and it is projected to reach 700 million by 2045.

This market is expected to witness significant growth due to the technological advancements in the devices. For example, the blood glucose and ketone testing meter by Foracare Inc., FORA 6 Gtel, comes with 3G/4G connectivity. With 5-Electrode Technology and strips made with gold, FORA 6 test strips guarantee high accuracy and precision. They measure six parameters: glucose, hematocrit, hemoglobin, B-ketone, total cholesterol, and uric acid in the blood. They can effortlessly transfer data to a TeleHealth System without pairing it with a smartphone. Hence, the market is expected to propel during the forecast period due to the factors mentioned above.

Key Market Trends

The Blood Ketone Monitoring Segment is Expected to Account for a Major Market Share

The blood ketone monitoring segment captured a significant share of the market as these devices help in the early identification of the production of ketones and may also warn of impending ketoacidosis, which may ultimately reduce the complications of diabetic ketoacidosis. The rising prevalence of diabetic ketoacidosis and diabetes is among the major factors augmenting the market growth. The rise in the geriatric and obese population worldwide is expected to boost the growth of the market. As per the World Health Organization (WHO), the global population aged 60 years and above is likely to reach 2 billion by 2050. According to Diabetes Facts & Figures updated in the International Diabetes Federation in September 2021, approximately 537 million adults were living with diabetes worldwide. It is expected to rise to 643 million by 2030 and 783 million by 2045. This may increase the demand in the blood ketone meter market as these devices measure the level of ketones in the blood.

This segment is expected to witness significant growth due to increasing partnerships and collaborations. For instance, in February 2020, global diabetes non-profit Beyond Type 1 announced a new partnership with the National Association of School Nurses to create awareness about Type 1 diabetes (T1D) warning signs. With this new partnership, awareness materials will be circulated to thousands of school nurses nationally in United States. Awareness programs make it easier for people at risk for diabetes to participate in evidence-based lifestyle change programs to reduce their risk of diabetes, which may drive the market during the forecast period. Market participants are getting Conformite Europeenne (CE) and Food and Drug Administration (FDA) approvals for their advanced blood ketone meters, which will help capture a larger market share and help people track their blood ketone levels easily with updated technological products. For instance, Abbots's FreeStyle Optium Neo, an ultra-thin, lightweight meter that fits in a pocket, can test both blood glucose and ketone readings in the same meter with accurate results. Thus, product approvals worldwide are likely to boost the market during the forecast period.

North America is Expected to Hold a Significant Market Share During the Forecast Period

North America dominates the blood ketone meter market. It is expected to do so during the forecast period due to various mergers, partnerships, and acquisitions by key players in the region. In March 2019, Keto Mojo, a blood glucose and ketone testing manufacturing company, entered a partnership with Heads Up Health, a software data analytics company for personal health, to develop Keto-Mojo App, which can be synchronized with the ketone meter. This integration will help Keto Mojo users constantly check their health profiles. In March 2020, EKF Diagnostics announced the launch of United States Food and Drug Administration Clinical Laboratory Improvement Amendments (FDA CLIA) waived B-ketone and glucose POC analyzer STAT-Site WB Analyzer in the US market. The STAT-Site WB is a dual-use whole blood B-ketone and glucose meter for professional use in the management of diabetes.

Better quality infrastructure in healthcare facilities and the high adoption of blood ketone meters, especially during the COVID-19 pandemic, across the region are projected to contribute to the market growth in North America. Government initiatives to promote glucose and ketone monitoring are estimated to drive the market significantly. According to the National Diabetes Prevention Program updated in the Centers for Disease Control in August 2021, the US government raised awareness programs like The National Diabetes Prevention Program to address the increasing burden of pre-diabetes and type 2 diabetes. This effort created partnerships between public and private organizations to offer cost-effective interventions and evidence-based treatments that help prevent type 2 diabetes across United States.

The increasing prevalence of diabetes is anticipated to create demand for blood ketone meters for measuring ketone levels. For instance, according to the CDC, around 10.5% of the US population was suffering from diabetes, and approximately 26.9 million people in United States were diagnosed with diabetes in 2020. As per the American Diabetes Association, in 2018, about 210,000 Americans under the age of 20 years were projected to have been diagnosed with diabetes. This rise in diabetes among the youth is expected to create the demand for blood ketone meters.

Competitive Landscape

The blood ketone meter market is moderately fragmented, with a few major players and small players. The market players are focusing on research and development to develop technologically advanced products in the market. Some of the major players in the market are Abbott Laboratories, Nova Biomedical, Nipro Corporation, TaiDoc Technology Corporation, ForaCare Inc., and A. Menarini Diagnostics Srl.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Diabetes
    • 4.2.2 Increasing Product Launches and Approvals
  • 4.3 Market Restraints
    • 4.3.1 Rising Instances of Product Recalls
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Product Type
    • 5.1.1 Blood Ketone Monitoring
    • 5.1.2 Blood Glucose and Ketone Monitoring
    • 5.1.3 Consumables
  • 5.2 Application
    • 5.2.1 Human
    • 5.2.2 Veterinary
  • 5.3 End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.2 Europe
    • 5.4.3 Asia-Pacific
    • 5.4.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Nova Biomedical
    • 6.1.3 Nipro Corporation
    • 6.1.4 TaiDoc Technology Corporation
    • 6.1.5 ForaCare Inc.
    • 6.1.6 A. Menarini Diagnostics Srl
    • 6.1.7 ACON Laboratories Inc.
    • 6.1.8 APEX Biotechnology Corporation
    • 6.1.9 EKF Diagnostics
    • 6.1.10 GlucoRx Ltd
    • 6.1.11 MED TRUST
    • 6.1.12 KETO-MOJO
    • 6.1.13 PortaScience Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS